Inhibitaxin


Inhibitaxin develops the autotaxin program which consists of a series of small molecule inhibitors spun out of Pfizer at the same time as Levicept. The most recent part of the seed activity has been a phenotype-wide screen (PHEWAS).

Inhibitaxin develops the autotaxin program which consists of a series of small molecule inhibitors spun out of Pfizer at the same time as Levicept. The most recent part of the seed activity has been a phenotype-wide screen (PHEWAS).

Company (Alive / Active)

Phone:

Fax:



Sandwich,
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Inhibitaxin $0M Jun 5, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Inhibitaxin Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)